• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠病毒感染后 S1 IgG 和中和抗体的产生和持续时间。

Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients.

机构信息

Instituto de Salud Pública, Universidad Veracruzana, Av. Luis Castelazo Ayala S/N, Col. Industrial Ánimas, 91190, Xalapa, Veracruz, México.

Centro de Investigaciones Biomédicas, Universidad Veracruzana, Xalapa, Veracruz, México.

出版信息

Infection. 2022 Apr;50(2):447-456. doi: 10.1007/s15010-021-01705-7. Epub 2021 Oct 19.

DOI:10.1007/s15010-021-01705-7
PMID:34668145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8525617/
Abstract

BACKGROUND

Antibody-mediated immune response plays an important role in protection against reinfection. In the case of SARS-CoV-2 infection, the maximum duration of antibody response is still unknown. In this work, the generation of neutralizing  antibodies (NAbs) and IgG antibodies against the S1 subunit (S1 IgG ) of SARS-CoV-2 and their possible duration were determined through decay models.

METHODS

132 participants with SARS-CoV-2 infection were classified according to the severity of the disease. Seroconversion and persistence of S1 IgG antibodies and NAbs were determined by ELISA, samples were taken at two different times post-infection and duration of those antibodies was estimated using Linear Mixed Models (LMMs).

RESULTS

The highest amount of S1 IgGs antibodies was associated with age (41 years or older), greater severity of COVID-19 and male gender. NAbs production was associated with the same variables, except for age. The percentage of NAbs decay is higher in the asymptomatic group (P = 0.033), while in S1 IgG antibodies decay, no statistical difference was found between the 4 severity groups. An exponential decay model was built by using a LMM and similarly, two dispersion regions where constructed. The duration of S1 IgG antibodies was 744 days (668-781) for first region and 744 days (453-1231) for the second. Regarding NAbs, an adaptative LMM was used to model a logistic function, determining a duration of 267 days (215-347).

CONCLUSION

Humoral immunity to SARS-CoV-2 infection depends on the severity of the disease, gender and age. This immune response could be long-lasting as for other coronaviruses.

摘要

背景

抗体介导的免疫反应在预防再感染中起着重要作用。就 SARS-CoV-2 感染而言,抗体反应的最长持续时间仍不清楚。在这项工作中,通过衰减模型确定了针对 SARS-CoV-2 的 S1 亚单位(S1 IgG)的中和抗体(NAb)和 IgG 抗体的产生及其可能的持续时间。

方法

根据疾病的严重程度,将 132 名 SARS-CoV-2 感染患者分为不同组别。通过 ELISA 确定 S1 IgG 抗体和 NAb 的血清转化率和持久性,在感染后两个不同时间点采集样本,并使用线性混合模型(LMMs)估计这些抗体的持续时间。

结果

S1 IgG 抗体的含量与年龄(41 岁或以上)、COVID-19 的严重程度和性别呈正相关。NAb 的产生与年龄呈正相关。无症状组的 NAb 衰减百分比较高(P=0.033),而在 S1 IgG 抗体衰减中,4 个严重程度组之间无统计学差异。使用 LMM 构建了指数衰减模型,并同样构建了两个离散区域。S1 IgG 抗体的持续时间为 744 天(668-781),第一个区域为 744 天(453-1231)。对于 NAb,使用适应性 LMM 对逻辑函数进行建模,确定持续时间为 267 天(215-347)。

结论

针对 SARS-CoV-2 感染的体液免疫依赖于疾病的严重程度、性别和年龄。这种免疫反应可能像其他冠状病毒一样具有持久性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/d39454323e4c/15010_2021_1705_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/1c171ab587dc/15010_2021_1705_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/ffda549bebba/15010_2021_1705_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/d39454323e4c/15010_2021_1705_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/1c171ab587dc/15010_2021_1705_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/ffda549bebba/15010_2021_1705_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/33c2/8525617/d39454323e4c/15010_2021_1705_Fig3_HTML.jpg

相似文献

1
Generation and persistence of S1 IgG and neutralizing antibodies in post-COVID-19 patients.新冠病毒感染后 S1 IgG 和中和抗体的产生和持续时间。
Infection. 2022 Apr;50(2):447-456. doi: 10.1007/s15010-021-01705-7. Epub 2021 Oct 19.
2
A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.一例 COVID-19 再感染病例:抗体在 SARS-CoV-2 感染中的作用。
CEN Case Rep. 2022 Nov;11(4):422-427. doi: 10.1007/s13730-022-00697-z. Epub 2022 Mar 9.
3
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulins using chemiluminescence immunoassay and its correlation with neutralizing antibodies.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)免疫球蛋白的化学发光免疫分析及其与中和抗体的相关性。
Virus Res. 2022 Oct 2;319:198852. doi: 10.1016/j.virusres.2022.198852. Epub 2022 Jul 11.
4
Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days.接种灭活疫苗后 160 天内血清抗 SARS-CoV-2 抗体的反应和持续时间。
Front Immunol. 2021 Dec 23;12:786554. doi: 10.3389/fimmu.2021.786554. eCollection 2021.
5
Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19?接种 COVID-19 疫苗后,人乳中能否检测到 SARS-CoV-2 抗体?
J Pediatric Infect Dis Soc. 2022 Apr 30;11(4):126. doi: 10.1093/jpids/piac024.
6
Evaluation of the correlation between the access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.评估 SARS-CoV-2 IgM 和 IgG II 抗体检测与 SARS-CoV-2 替代病毒中和试验之间的相关性。
J Med Virol. 2022 Jan;94(1):335-341. doi: 10.1002/jmv.27338. Epub 2021 Oct 5.
7
A stronger antibody response in increased disease severity of SARS-CoV-2.在 SARS-CoV-2 疾病严重程度增加的情况下,抗体反应增强。
BMC Infect Dis. 2024 Jan 2;24(1):17. doi: 10.1186/s12879-023-08923-4.
8
Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients.康复的 COVID-19 患者中严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)刺突蛋白特异性和中和抗体的长期持久性。
PLoS One. 2022 Apr 21;17(4):e0267102. doi: 10.1371/journal.pone.0267102. eCollection 2022.
9
Kinetics of SARS-CoV-2 Specific and Neutralizing Antibodies over Seven Months after Symptom Onset in COVID-19 Patients.COVID-19 患者症状出现后七个月内 SARS-CoV-2 特异性和中和抗体的动力学。
Microbiol Spectr. 2021 Oct 31;9(2):e0059021. doi: 10.1128/Spectrum.00590-21. Epub 2021 Sep 22.
10
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers.两剂 BNT162b2 mRNA 疫苗接种后,中和抗体在意大利医护人员队列中的 sVNT 作用。
Clin Chem Lab Med. 2022 Mar 17;60(6):934-940. doi: 10.1515/cclm-2022-0170. Print 2022 May 25.

引用本文的文献

1
S309-CAR-NK cells bind the Omicron variants and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.S309嵌合抗原受体自然杀伤细胞(S309-CAR-NK细胞)可结合奥密克戎变异株,并降低人源化血管紧张素转换酶2(ACE2)-NOD/SCID/IL2rgamma基因敲除(NSG)小鼠体内的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒载量。
J Virol. 2024 Jun 13;98(6):e0003824. doi: 10.1128/jvi.00038-24. Epub 2024 May 20.
2
Nine-Month Trend of IgG Antibody Persistence and Associated Symptoms Post-SARS-CoV-2 Infection.新型冠状病毒感染后IgG抗体持久性及相关症状的九个月趋势
Healthcare (Basel). 2024 May 5;12(9):948. doi: 10.3390/healthcare12090948.
3
Dried blood spot eluates are suitable for testing of SARS-CoV-2 IgG antibodies targeting Spike protein 1 and Nucleocapsid protein.
干血斑洗脱液适用于检测针对刺突蛋白1和核衣壳蛋白的新型冠状病毒2型IgG抗体。
Biochem Biophys Rep. 2023 Jul;34:101479. doi: 10.1016/j.bbrep.2023.101479. Epub 2023 Apr 25.
4
Long-Term Follow-Up of Patients Needing Extracorporeal Membrane Oxygenation Following a Critical Course of COVID-19.COVID-19重症病程后需要体外膜肺氧合的患者的长期随访
Life (Basel). 2023 Apr 20;13(4):1054. doi: 10.3390/life13041054.
5
Kinetics of SARS-CoV-2 IgM and IgG Antibodies 3 Months after COVID-19 Onset in Moroccan Patients.摩洛哥患者 COVID-19 发病 3 个月后 SARS-CoV-2 IgM 和 IgG 抗体的动力学。
Am J Trop Med Hyg. 2022 Dec 12;108(1):145-154. doi: 10.4269/ajtmh.22-0448. Print 2023 Jan 11.
6
Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses.严重急性呼吸综合征冠状病毒 2 感染抗体反应的动力学。
Front Immunol. 2022 Aug 5;13:864278. doi: 10.3389/fimmu.2022.864278. eCollection 2022.
7
Dynamic changes of serum SARS-CoV-2 antibody levels in COVID-19 patients.新型冠状病毒肺炎患者血清中新型冠状病毒2抗体水平的动态变化
J Infect. 2022 Jul;85(1):90-122. doi: 10.1016/j.jinf.2022.04.032. Epub 2022 Apr 21.